TypeIV

Company Overview

Snapshot

Founded in February 2017 by Boaz Shetzer and Ziv Kalderon, TypeIV operates with 1–10 employees. The company is currently in a Pre-Funding stage, focusing on developing its wellness solution for contact allergies.

Business overview

TypeIV is a wellness solution provider specializing in assisting individuals with contact allergies. The company's core technology is a mobile application that enables users to scan consumer products and analyze their ingredients to identify potential allergens. This service translates complex medical information into actionable day-to-day behavior, simplifying the process of purchasing safe products. TypeIV operates within the Health Tech & Life Sciences sector, specifically targeting Digital Healthcare and Digital Therapeutics, serving patients and consumers in geomarkets including the Americas, Japan, China, Germany, and the United States.

Company Intelligence Q&A

What is TypeIV's primary focus?

TypeIV focuses on providing a wellness solution for individuals with contact allergies, helping them identify and avoid allergenic ingredients in consumer products.

When was TypeIV founded?

TypeIV was founded in February 2017.

Who are the founders of TypeIV?

TypeIV was co-founded by Boaz Shetzer, who serves as CEO, and Ziv Kalderon, who serves as CTO.

What markets does TypeIV target?

TypeIV targets geomarkets including the Americas, Japan, China, Germany, and the United States.

What is the current product stage of TypeIV?

TypeIV's product is currently in the Alpha stage, with an app available on both the Apple App Store and Google Play Store.